PEOPLE - Cambridge Heart makes appointment:
This article was originally published in Clinica
Executive Summary
US cardiac diagnostics firm Cambridge Heart (Bedford, Massachusetts) has appointed Roderick de Greef as CFO. Formerly, Mr de Greef was executive vice-president, CFO and secretary for California-based cardiac defibrillator firm Cardiac Science. He also serves on the boards of: stent developer Endologix and dental device maker, Dental View.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.